The combined effects of BRD4 and CDK9 inhibition on blocking tumor cell proliferation might be independent of the MYC- expression, as H1792 is a MYC-amplified cell line and HeLa cells do not harbour any MYC alteration. This evidence concerns the gene MYC and neoplasm.